The clinical spectrum ofTrichomonas vaginalisinfection and challenges to management

Prevalence of Trichomonas vaginalis and Coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as Determined by the Aptima Trichomonas vaginalis Nucleic Acid Amplification Assay

(2012) C. C. Ginocchio et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: successful treatment with boric acid

(2012) Christina Muzny et al.   Sexual Health

Molecular Testing for Trichomonas vaginalis in Women: Results from a Prospective U.S. Clinical Trial

(2011) J. R. Schwebke et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Resistant Trichomoniasis: Successful Treatment With Combination Therapy

(2011) Paul Nyirjesy et al.   SEXUALLY TRANSMITTED DISEASES

A Randomized Treatment Trial: Single Versus 7-Day Dose of Metronidazole for The Treatment of Trichomonas Vaginalis Among HIV-Infected Women

(2010) Patricia Kissinger et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Treatment of metronidazole-resistantTrichomonas vaginalis

(2009) Linda M. Goldman et al.   Sexual Health

Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity

(2008) Donna J. Helms et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY